Latest Product Development News

Echo IQ has locked in a pivotal exclusive data licensing deal with Advara HeartCare, gaining access to as many as one million de-identified echocardiography studies, a move set to turbocharge its cardiovascular AI development.

Echo IQ has raised approximately A$110 million through a heavily supported institutional placement to fund its US commercial rollout and speed up development of its AI-driven cardiovascular diagnostics.

Chimeric Therapeutics has appointed Hawkesbury Partners to lead a strategic review aimed at exploring options to enhance shareholder value, reflecting concerns that its market cap undervalues its clinical assets and infrastructure.

CONNEQT Health Limited is offering eligible shareholders a share purchase plan to raise up to $0.5 million at a 24.3% discount, aiming to fund its next growth phase in vascular health technology.

Sparc Technologies has unveiled SparcESTM, a graphene additive range designed for electrostatic and conductive coatings, aiming to disrupt a $1.65 billion market driven by data centres, semiconductors, and EV battery manufacturing.

Develop Global has locked in a major A$70 million mining contract for its Pioneer Dome lithium project, setting the stage for first sales in the December quarter of 2026. Strong drilling results and a binding offtake deal with Trafigura underpin the project’s fast-tracked development and cashflow outlook.

Comms Group has agreed to divest its onPlatinum IT managed services division for A$30 million, a move that simplifies its business and boosts balance sheet strength ahead of FY27.

Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.

ArborGen Holdings reported a solid FY26 with record revenue driven by Brazil expansion and a 31% EBITDA increase, offsetting a challenging US market. Leadership changes and operational discipline mark the company’s path forward.

EROAD Limited reported stable FY26 revenue of NZD 195 million amid a $134.7 million North American impairment, unveiling a strategic reset centred on ANZ growth and its expanding electronic Road User Charges platform.

TZ Limited (ASX:TZL) has launched a 1-for-4 non-renounceable entitlement offer priced at 3 cents per share, aiming to raise approximately $2.58 million to reduce debt and fund growth initiatives.

Spenda Limited has pushed back the closing date for its retail entitlement offer by five days, aiming to complete a critical $8.545 million capital raise to support its turnaround plan and reduce debt.